{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:28:20Z","timestamp":1789709300307,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park","doi-asserted-by":"publisher","award":["Z221100007422045"],"award-info":[{"award-number":["Z221100007422045"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"publisher","award":["ZLRK202304"],"award-info":[{"award-number":["ZLRK202304"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-19599-w","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:25:00Z","timestamp":1781972700000},"page":"9285-9293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Observation on the Surgical Efficacy of Neoadjuvant Immunotherapy Combined with Chemotherapy for Locally Advanced Hypopharyngeal Cancer"],"prefix":"10.1245","volume":"33","author":[{"given":"Lifei","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jugao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"issue":"6","key":"19599_CR1","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.mcna.2018.06.012","volume":"102","author":"K Yan","year":"2018","unstructured":"Yan K, Agrawal N, Gooi Z. Head and neck masses. Med Clin North Am. 2018;102(6):1013\u201325.","journal-title":"Med Clin North Am."},{"key":"19599_CR2","unstructured":"Subspecialty Group of Head and Neck Surgery, Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery; Subspecialty Group of Head and Neck Surgery, Society of Otorhinolaryngology Head and Neck Surgery, Chinese Medical Association. [Expert consensus on surgery and comprehensive treatment of hypopharyngeal carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017; 52(1):16\u201324. (Chinese)"},{"issue":"10318","key":"19599_CR3","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/S0140-6736(21)01550-6","volume":"398","author":"MD Mody","year":"2021","unstructured":"Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF. Head and neck cancer. Lancet. 2021;398(10318):2289\u201399.","journal-title":"Lancet."},{"issue":"11","key":"19599_CR4","first-page":"3282","volume":"48","author":"WJ Blot","year":"1988","unstructured":"Blot WJ, Mclaughlin JK, Winn DM, Austin DF, Fraumeni JF. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48(11):3282\u20137.","journal-title":"Cancer Res"},{"key":"19599_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/jnci\/86.2.131","volume":"2","author":"GL Day","year":"1994","unstructured":"Day GL, Blot WJ, Shore RE, Mclauglin JK, Austin DF, Greenberg RS, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst. 1994;2:131\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"19599_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jnci\/djp007","volume":"101","author":"Y Pointreau","year":"2009","unstructured":"Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J, Faivre S, Guerrif S, Alfonsi M, Calais G. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst. 2009;101(7):498\u2013506.","journal-title":"J Natl Cancer Inst."},{"key":"19599_CR7","doi-asserted-by":"crossref","unstructured":"Burtness B, Harrington KJ, Greil R, Souli\u00e8res D, Tahara M, de Castro G Jr, Psyrri A, Bast\u00e9 N, Neupane P, Bratland \u00c5, Fuereder T, Hughes BGM, Mes\u00eda R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, Gonz\u00e1lez Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D; KEYNOTE-048 Investigators. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet. 2019;394(10212):1915\u20131928.","DOI":"10.1016\/S0140-6736(19)32591-7"},{"issue":"2","key":"19599_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):247.","journal-title":"Eur J Cancer"},{"issue":"7","key":"19599_CR9","first-page":"870","volume":"127","author":"AY Chen","year":"2001","unstructured":"Chen AY, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, Goepfert H. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M.D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg. 2001;127(7):870\u20136.","journal-title":"Arch Otolaryngol Head Neck Surg."},{"issue":"6","key":"19599_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000066150","volume":"54","author":"P Yu","year":"2002","unstructured":"Yu P, Revis J, Wuyts FL, Zanaret M, Giovanni A. Correlation of instrumental voice evaluation with perceptual voice analysis using a modified visual analog scale. Folia Phoniatr Logop. 2002;54(6):271\u201381.","journal-title":"Folia Phoniatr Logop."},{"issue":"3","key":"19599_CR11","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin."},{"key":"19599_CR12","unstructured":"National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: head and neck. Version 1.2025."},{"issue":"10","key":"19599_CR13","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1007\/s00405-016-3919-3","volume":"273","author":"A Bozec","year":"2016","unstructured":"Bozec A, Benezery K, Ettaiche M, Chamorey E, Vandersteen C, Dassonville O, Poissonnet G, Riss JC, Hannoun-L\u00e9vi JM, Chand ME, Leysalle A, Saada E, Guigay J, Sudaka A, Demard F, Santini J, Peyrade F. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors. Eur Arch Otorhinolaryngol. 2016;273(10):3299\u2013306.","journal-title":"Eur Arch Otorhinolaryngol."},{"issue":"7","key":"19599_CR14","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","volume":"17","author":"TY Seiwert","year":"2016","unstructured":"Seiwert TY, Burtness B, Mehra R, Weiss J, Berger R, Eder JP, Heath K, McClanahan T, Lunceford J, Gause C, Cheng JD, Chow LQ. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. Lancet Oncol. 2016;17(7):956\u201365.","journal-title":"Lancet Oncol."},{"issue":"15","key":"19599_CR15","doi-asserted-by":"publisher","first-page":"1466310","DOI":"10.3389\/fimmu.2024.1466310","volume":"31","author":"W Gao","year":"2024","unstructured":"Gao W, Feng L, Zhao X, Huang Z, Chen D, Yin G, Guo W, Zhong Q, Chen X, Fang J, Zhang Y, Huang Z. Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma. Front Immunol. 2024;31(15):1466310.","journal-title":"Front Immunol."},{"issue":"4","key":"19599_CR16","first-page":"343","volume":"59","author":"K Wang","year":"2024","unstructured":"Wang K, Zhang W, Gui L, He XH, Wang JB, Lu HZ, Li DZ, Liu C, Guo ZZ, Xu M, Liu SY, Wang XL. The efficacy and safety of immunotherapy combined with chemotherapy neoadjuvant in locally advanced resectable hypopharyngeal squamous cell carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024;59(4):343\u20139 (Chinese).","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi."},{"issue":"15","key":"19599_CR17","doi-asserted-by":"publisher","first-page":"1364799","DOI":"10.3389\/fimmu.2024.1364799","volume":"8","author":"SG Wu","year":"2024","unstructured":"Wu SG, Wang RJ, Zhou Y, Luo XY. Neoadjuvant therapy with chemotherapy and immune checkpoint inhibitor for laryngeal function preservation in locally advanced hypopharyngeal cancer. Front Immunol. 2024;8(15):1364799.","journal-title":"Front Immunol."},{"issue":"19","key":"19599_CR18","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","volume":"375","author":"RL Ferris","year":"2016","unstructured":"Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Geese WJ, Kopit J, Shaw JW, Gillison ML. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med. 2016;375(19):1856\u201367.","journal-title":"N Engl J Med."},{"key":"19599_CR19","doi-asserted-by":"crossref","unstructured":"Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, Chernock R, Tahara M, Harrington KJ, Klochikhin AL, Bra\u00f1a I, Vasconcelos Alves G, Hughes BGM, Oliva M, Pinto Figueiredo Lima I, Ueda T, Rutkowski T, Schroeder U, Mauz PS, Fuereder T, Laban S, Oridate N, Popovtzer A, Mach N, Korobko Y, Costa DA, Hooda-Nehra A, Rodriguez CP, Bell RB, Manschot C, Benjamin K, Gumuscu B, Adkins D; KEYNOTE-689 Investigators. Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer. N Engl J Med. 2025; 393(1):37\u201350.","DOI":"10.1056\/NEJMoa2415434"},{"issue":"7","key":"19599_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jnci\/djp007","volume":"101","author":"Y Pointreau","year":"2009","unstructured":"Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J, Faivre S, Guerrif S, Alfonsi M, Calais G. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst. 2009;101(7):498\u2013506.","journal-title":"J Natl Cancer Inst."},{"issue":"4","key":"19599_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41590-020-0620-x","volume":"21","author":"B Diskin","year":"2020","unstructured":"Diskin B, Adam S, Cassini MF, Sanchez G, Liria M, Aykut B, Buttar C, Li E, Sundberg B, Salas RD, Chen R, Wang J, Kim M, Farooq MS, Nguy S, Fedele C, Tang KH, Chen T, Wang W, Hundeyin M, Rossi JAK, Kurz E, Haq MIU, Karlen J, Kruger E, Sekendiz Z, Wu D, Shadaloey SAA, Baptiste G, Werba G, Selvaraj S, Loomis C, Wong KK, Leinwand J, Miller G. PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer. Nat Immunol. 2020;21(4):442\u201354.","journal-title":"Nat Immunol."},{"issue":"10","key":"19599_CR22","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1007\/s00405-016-3919-3","volume":"273","author":"A Bozec","year":"2016","unstructured":"Bozec A, Benezery K, Ettaiche M, Chamorey E, Vandersteen C, Dassonville O, Poissonnet G, Riss JC, Hannoun-L\u00e9vi JM, Chand ME, Leysalle A, Saada E, Guigay J, Sudaka A, Demard F, Santini J, Peyrade F. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors. Eur Arch Otorhinolaryngol. 2016;273(10):3299\u2013306.","journal-title":"Eur Arch Otorhinolaryngol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19599-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19599-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19599-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:53:34Z","timestamp":1789667614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19599-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["19599"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19599-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no competing interests. This study was not influenced by any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki and was approved by the Ethics Committee of Beijing Tongren Hospital, Capital Medical University (approval no.: TREC2023-KY009). All participants provided written informed consent before enrollment.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}